As part of the erudite – the actual conference with the international interest ” New technological processes in pediatric science, practice and education of ” given away the memory of academician of AMS of Ukraine BJ Reznik and traces the presence of aid firms ‘ Megakom “was shown the report Gennady Lezhenko, scientist , doctor of medical lessons , manager of the department lazaretnoy pediatric and infant infectious diseases of the Zaporozhye Government Medical Institute . The question of the report began the strategy and policy of antibiotic treatment in the presence of acute intestinal infections in a child .
The speaker focused the interest of being there in such a case , the fact that critical intestinal infections are considered one of the more well-known infectious diseases in a child , especially premature year . In the world of enormous importance acquires creating layouts antibiotic pointed intestinal infections, stimulated by pathogenic microorganisms. It is necessary to highlight , then that evidence to the destination of antibiotic therapy in the child are considered : mid-weight or difficult diarrhea ; septic model of the disease (persistence of bacteria in the bloodstream);the formation of a sharp enterobacterial intestinal infection in the background of a monthly coffin ; sickle cell anemia or immunodeficiency capital . The presence of this G. Lezhenko highlighted the interest in this , that if the patient is in a light stay , in this case it is most rational to provide an advantage to oral medications , what will give the opportunity to exclude emotional trauma, which the guys acquire the presence of intramuscular injection of substances .
When the selection of the antibiotic with a view to oral administration method , according to the judgment G. Lezhenko, should be taken into account in this case , what Phytoncides shall function as well as in the lumen of the intestinal tract , thus in its wall. In addition to this, preferably , in order for someone to have the least influence in the normal flora of the intestinal tract, along with great initiative in the relationship of pathogenic bacteria . In addition, the auxiliary superiority of therapeutic resources in this case is his ability to express antimicrobial dynamism in the bloodstream, bile-excreting routes and bile.
Speakeroutlined , though due to the relation mainly with the above conditions huge popularity among medical professionals using the product Cefixime cost (Cefixime cost), presents itself antibiotic cephalosporin system generation III, that in the pharmaceutical bargaining Ukraine assumes firm “Megakom”. Someone besides stated , the fact that the product may safely usein the framework of the staged treatment of III generation cephalosporins.
The bioavailability of CEFIX is 40–50%. Someone will emit in FIG powder with the aim of producing a suspension SRT mg / 5 ml ( according THIRTY and sixty milliliters ) and capsules according CHETIRESTA mg, No 5. G. Lezhenko designated , then that , just as the principle , the presence of sharp intestinal infection This therapeutic method is used at a dose of 8 mg / kg / day ( according to 4 mg / kg / day by 12 h 2 once a day ). A child with a body weight of the most FIFTY kilogram or in a year more than 12 years old, is given according to CHURREST mg / day 1-2 once a day . The duration of treatment is 5 days. CEFIX
Speakerconcentrated interest in being there in in such a case , the fact that , in accordance with information Russian and foreign studies , most of the frequent pathogens pointed intestinal infections, such as well as Escherichia coli, Klebsiella spp., Proteus mirabilis, Shigella spp., Salmonella spp., Salmonella typhimurium is very sensitive to Cefixime cost. Thus , in accordance with the advice of the European Community Infantgastroenterologists, hepatologists and nutritiologists and the European community of infant infectious diseases , the presence of cured shigellosis in a child Cefixime cost must be used orally at a dose of 8 mg / kg / day for 5 days .
In Ukraine, since January 2011, critical intestinal infections have been included in the list of evidence for the use of CEFIX suspension . The date period acquired an extensive skill The use of this substance is the presence of acute intestinal infections in a child , and in addition this is timed to several studies . Thus , there is presented , then that presence using Cefixime cost orally at a child with a sharp intestinal infection a significant impact material was observed in 80% of patients , and small – 20% (Kramarev SA, 2007). Presence given, According to the results of the study , the therapeutic method characterized by a suitable profile of security .
When you study the performance and profile security presence pointed intestinal infections as part of step- therapy together with substances cephalosporin down there found what Cefixime cost has a big impact and optimalportability (Kramarev SA, 2009). It is necessary to distinguish , though in this finding have assistance SIXTY child in the year from 6 months up to 7 years with invasive diarrhea.
As part of another study , in which 46 children took assistance in the year from 6 months up to 3 years with a sharp intestinal infection generated by disease-causing microorganisms, there was laid a comparison of the performance of the substance CEFIX for oral use with ceftriaxone and cefotaxime for intravenous use ( Kovaley SV, Olkhovskaya OM, 2009).